S&P 500   3,465.39 (+0.34%)
DOW   28,335.57 (-0.10%)
QQQ   284.74 (+0.20%)
AAPL   115.04 (-0.61%)
MSFT   216.23 (+0.62%)
FB   284.79 (+2.40%)
GOOGL   1,632.98 (+1.64%)
AMZN   3,204.40 (+0.88%)
TSLA   420.63 (-1.21%)
NVDA   543.61 (+1.72%)
BABA   309.92 (+1.19%)
CGC   19.73 (-2.81%)
GE   7.63 (-1.17%)
MU   52.85 (-2.81%)
AMD   81.96 (+3.20%)
T   27.82 (-1.63%)
F   8.16 (-0.61%)
ACB   4.68 (-3.51%)
GILD   60.79 (+0.20%)
NFLX   488.28 (+0.63%)
BA   167.36 (-1.01%)
NIO   27.16 (-0.80%)
DIS   128.35 (+0.62%)
S&P 500   3,465.39 (+0.34%)
DOW   28,335.57 (-0.10%)
QQQ   284.74 (+0.20%)
AAPL   115.04 (-0.61%)
MSFT   216.23 (+0.62%)
FB   284.79 (+2.40%)
GOOGL   1,632.98 (+1.64%)
AMZN   3,204.40 (+0.88%)
TSLA   420.63 (-1.21%)
NVDA   543.61 (+1.72%)
BABA   309.92 (+1.19%)
CGC   19.73 (-2.81%)
GE   7.63 (-1.17%)
MU   52.85 (-2.81%)
AMD   81.96 (+3.20%)
T   27.82 (-1.63%)
F   8.16 (-0.61%)
ACB   4.68 (-3.51%)
GILD   60.79 (+0.20%)
NFLX   488.28 (+0.63%)
BA   167.36 (-1.01%)
NIO   27.16 (-0.80%)
DIS   128.35 (+0.62%)
S&P 500   3,465.39 (+0.34%)
DOW   28,335.57 (-0.10%)
QQQ   284.74 (+0.20%)
AAPL   115.04 (-0.61%)
MSFT   216.23 (+0.62%)
FB   284.79 (+2.40%)
GOOGL   1,632.98 (+1.64%)
AMZN   3,204.40 (+0.88%)
TSLA   420.63 (-1.21%)
NVDA   543.61 (+1.72%)
BABA   309.92 (+1.19%)
CGC   19.73 (-2.81%)
GE   7.63 (-1.17%)
MU   52.85 (-2.81%)
AMD   81.96 (+3.20%)
T   27.82 (-1.63%)
F   8.16 (-0.61%)
ACB   4.68 (-3.51%)
GILD   60.79 (+0.20%)
NFLX   488.28 (+0.63%)
BA   167.36 (-1.01%)
NIO   27.16 (-0.80%)
DIS   128.35 (+0.62%)
S&P 500   3,465.39 (+0.34%)
DOW   28,335.57 (-0.10%)
QQQ   284.74 (+0.20%)
AAPL   115.04 (-0.61%)
MSFT   216.23 (+0.62%)
FB   284.79 (+2.40%)
GOOGL   1,632.98 (+1.64%)
AMZN   3,204.40 (+0.88%)
TSLA   420.63 (-1.21%)
NVDA   543.61 (+1.72%)
BABA   309.92 (+1.19%)
CGC   19.73 (-2.81%)
GE   7.63 (-1.17%)
MU   52.85 (-2.81%)
AMD   81.96 (+3.20%)
T   27.82 (-1.63%)
F   8.16 (-0.61%)
ACB   4.68 (-3.51%)
GILD   60.79 (+0.20%)
NFLX   488.28 (+0.63%)
BA   167.36 (-1.01%)
NIO   27.16 (-0.80%)
DIS   128.35 (+0.62%)
Log in
NASDAQ:SIBN

SI-Bone Stock Forecast, Price & News

$22.16
-0.01 (-0.05 %)
(As of 10/23/2020 03:59 PM ET)
Add
Compare
Today's Range
$22.04
Now: $22.16
$22.79
50-Day Range
$20.96
MA: $23.03
$24.67
52-Week Range
$7.20
Now: $22.16
$26.41
Volume7,992 shs
Average Volume230,562 shs
Market Capitalization$634.44 million
P/E RatioN/A
Dividend YieldN/A
Beta1.37
SI-BONE, Inc., a medical device company, develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. It offers iFuse, an implant system to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that causes lower back pain. The company was founded in 2008 and is headquartered in Santa Clara, California.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 2.5Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.29 out of 5 stars

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:SIBN
CUSIPN/A
CIKN/A
Phone408-207-0700
Employees183

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$67.30 million
Book Value$2.52 per share

Profitability

Net Income$-38,400,000.00

Miscellaneous

Market Cap$634.44 million
Next Earnings Date11/2/2020 (Confirmed)
OptionableNot Optionable
$22.16
-0.01 (-0.05 %)
(As of 10/23/2020 03:59 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive SIBN News and Ratings via Email

Sign-up to receive the latest news and ratings for SIBN and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











SI-Bone (NASDAQ:SIBN) Frequently Asked Questions

How has SI-Bone's stock been impacted by Coronavirus?

SI-Bone's stock was trading at $15.32 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, SIBN stock has increased by 44.6% and is now trading at $22.16.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of SI-Bone?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for SI-Bone in the last year. There are currently 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for SI-Bone
.

When is SI-Bone's next earnings date?

SI-Bone is scheduled to release its next quarterly earnings announcement on Monday, November 2nd 2020.
View our earnings forecast for SI-Bone
.

How can I listen to SI-Bone's earnings call?

SI-Bone will be holding an earnings conference call on Monday, November 2nd at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were SI-Bone's earnings last quarter?

SI-Bone Inc (NASDAQ:SIBN) posted its quarterly earnings results on Monday, August, 3rd. The company reported ($0.44) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.64) by $0.20. The business had revenue of $14.05 million for the quarter, compared to the consensus estimate of $9.48 million. SI-Bone had a negative return on equity of 51.27% and a negative net margin of 68.27%.
View SI-Bone's earnings history
.

What guidance has SI-Bone issued on next quarter's earnings?

SI-Bone issued an update on its third quarter 2020 Pre-Market earnings guidance on Thursday, October, 8th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $20.1-20.4 million, compared to the consensus revenue estimate of $15.52 million.

What price target have analysts set for SIBN?

6 analysts have issued 12-month target prices for SI-Bone's stock. Their forecasts range from $24.00 to $27.00. On average, they expect SI-Bone's share price to reach $25.33 in the next twelve months. This suggests a possible upside of 14.3% from the stock's current price.
View analysts' price targets for SI-Bone
.

Are investors shorting SI-Bone?

SI-Bone saw a increase in short interest in September. As of September 30th, there was short interest totaling 445,500 shares, an increase of 31.4% from the September 15th total of 339,100 shares. Based on an average trading volume of 204,300 shares, the short-interest ratio is currently 2.2 days. Currently, 2.1% of the shares of the company are short sold.
View SI-Bone's Short Interest
.

Who are some of SI-Bone's key competitors?

What other stocks do shareholders of SI-Bone own?

Who are SI-Bone's key executives?

SI-Bone's management team includes the following people:
  • Mr. Jeffrey W. Dunn, CEO, Pres & Chairman (Age 63)
  • Dr. Mark A. Reiley M.D., Founder & Director (Age 68)
  • Ms. Laura A. Francis, Chief Financial Officer (Age 52)
  • Mr. Anthony J. Recupero, Chief Commercial Officer (Age 61)
  • Dr. Scott A. Yerby, Chief Technology Officer (Age 51)

When did SI-Bone IPO?

(SIBN) raised $84 million in an IPO on Wednesday, October 17th 2018. The company issued 6,000,000 shares at a price of $13.00-$15.00 per share. Morgan Stanley and BofA Merrill Lynch served as the underwriters for the IPO and Canaccord Genuity and JMP Securities were co-managers.

What is SI-Bone's stock symbol?

SI-Bone trades on the NASDAQ under the ticker symbol "SIBN."

Who are SI-Bone's major shareholders?

SI-Bone's stock is owned by a number of institutional and retail investors. Top institutional investors include Ritholtz Wealth Management (0.04%). Company insiders that own SI-Bone stock include Anthony J Recupero, Jeffrey W Dunn, John Gordon Freund, Laura Francis, Mark A Reiley, Michael A Pisetsky, Scott A Yerby, Skyline Venture Partners V Lp and W Carlton Reckling.
View institutional ownership trends for SI-Bone
.

Which major investors are buying SI-Bone stock?

SIBN stock was purchased by a variety of institutional investors in the last quarter, including Ritholtz Wealth Management.
View insider buying and selling activity for SI-Bone
.

How do I buy shares of SI-Bone?

Shares of SIBN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is SI-Bone's stock price today?

One share of SIBN stock can currently be purchased for approximately $22.16.

How big of a company is SI-Bone?

SI-Bone has a market capitalization of $634.44 million and generates $67.30 million in revenue each year. The company earns $-38,400,000.00 in net income (profit) each year or ($1.55) on an earnings per share basis. SI-Bone employs 183 workers across the globe.

What is SI-Bone's official website?

The official website for SI-Bone is www.si-bone.com.

How can I contact SI-Bone?

SI-Bone's mailing address is 471 EL CAMINO REAL SUITE 101, SANTA CLARA CA, 95050. The company can be reached via phone at 408-207-0700 or via email at [email protected]

This page was last updated on 10/23/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.